Helix Biopharma Corp.TSX: HBP

Helix BioPharma Corp Achieves Last-Patient-Out in Its Phase II Trial of Topical Interferon Alpha-2b in Patients with Ano-Genital Warts

Mar 22, 2010 at 6:01 AM UTC · Issued by Helix Biopharma Corp. via CNW

AURORA, Ontario, Mar. 22, 2010 (Canada NewsWire Group) -- /CNW/ --

Company analysis